0001683168-20-001272.txt : 20200424
0001683168-20-001272.hdr.sgml : 20200424
20200424161555
ACCESSION NUMBER: 0001683168-20-001272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200423
FILED AS OF DATE: 20200424
DATE AS OF CHANGE: 20200424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dal Poggetto John
CENTRAL INDEX KEY: 0001791040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33216
FILM NUMBER: 20815137
MAIL ADDRESS:
STREET 1: 1129 N. MCDOWELL BLVD
CITY: PETALUMA
STATE: CA
ZIP: 94954
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001367083
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680423298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 1129 N. MCDOWELL BLVD.
CITY: PETALUMA
STATE: CA
ZIP: 94954
BUSINESS PHONE: 707-283-0550
MAIL ADDRESS:
STREET 1: 1129 N. MCDOWELL BLVD.
CITY: PETALUMA
STATE: CA
ZIP: 94954
FORMER COMPANY:
FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc.
DATE OF NAME CHANGE: 20060622
4
1
ownership.xml
X0306
4
2020-04-23
0
0001367083
Sonoma Pharmaceuticals, Inc.
SNOA
0001791040
Dal Poggetto John
C/O SONOMA PHARMACEUTICALS, INC.
1129 N. MCDOWELL BLVD
PETALUMA
CA
94954
0
1
0
0
Chief Financial Officer
Common Stock, $0.0001 par value
2020-04-23
4
A
0
3086
A
3201
D
The shares were granted pursuant to the mutual separation and release agreement dated April 14, 2020.
/s/ John Dal Poggetto
2020-04-24